ERYTHROCYANOSIS

ERYTHROCYANOSIS was reported 15 times

ERYTHROCYANOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Blood Viscosity Reducer [EPC] 1 0.0002
1 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
2 Prostaglandin Analog [EPC] 1 0.0000
3 Factor Xa Inhibitor [EPC] 2 0.0000
4 Leukocyte Growth Factor [EPC] 1 0.0000
5 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
6 beta-Adrenergic Blocker [EPC] 1 0.0000
7 Loop Diuretic [EPC] 1 0.0000
8 Proton Pump Inhibitor [EPC] 1 0.0000